| # | Drug | Count |
|---|---|---|
| 0 | NATALIZUMAB | 24 |
| 1 | AGALSIDASE BETA | 19 |
| 2 | INTERFERON BETA-1A | 9 |
| 3 | ROMIPLOSTIM | 5 |
| 4 | EPOETIN ALFA | 3 |
| 5 | AZATHIOPRINE | 2 |
| 6 | GLATIRAMER ACETATE | 2 |
| 7 | OMALIZUMAB | 2 |
| 8 | PREDNISOLONE | 2 |
| 9 | PREDNISOLONE ORAL | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AGALSIDASE BETA | 19 | 0.0020 |
| 1 | ALGLUCOSIDASE ALFA | 1 | 0.0004 |
| 2 | ROMIPLOSTIM | 5 | 0.0003 |
| 3 | EPOETIN ALFA | 3 | 0.0003 |
| 4 | IMIGLUCERASE | 1 | 0.0002 |
| 5 | PERINDOPRIL ERBUMINE | 1 | 0.0002 |
| 6 | RAMELTEON | 1 | 0.0001 |
| 7 | NATALIZUMAB | 24 | 0.0001 |
| 8 | DASPONE | 1 | 0.0001 |
| 9 | DAPSONE GEL, 5% | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 19 |
| 1 | Interferon beta [EPC] | 9 |
| 2 | Corticosteroid [EPC] | 5 |
| 3 | Thrombopoietin Receptor Agonist [EPC] | 5 |
| 4 | Anti-IgE [EPC] | 2 |
| 5 | Purine Antimetabolite [EPC] | 2 |
| 6 | Vitamin C [EPC] | 2 |
| 7 | Angiotensin 2 Receptor Blocker [EPC] | 1 |
| 8 | Azole Antifungal [EPC] | 1 |
| 9 | Bile Acid [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 19 | 0.0020 |
| 1 | Thrombopoietin Receptor Agonist [EPC] | 5 | 0.0003 |
| 2 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 1 | 0.0003 |
| 3 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 4 | Sulfone [EPC] | 1 | 0.0001 |
| 5 | Melatonin Receptor Agonist [EPC] | 1 | 0.0001 |
| 6 | Interferon beta [EPC] | 9 | 0.0000 |
| 7 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Bile Acid [EPC] | 1 | 0.0000 |
| 9 | Thiazide-like Diuretic [EPC] | 1 | 0.0000 |